Dopamine receptor pharmacologyPhilip Seeman(University of Toronto), Hubert H.M. Van Tol(University of Toronto)Trends in Pharmacological SciencesJuly 1, 199410.1016/0165-6147(94)90323-9Cited by 962SaveCiteExport RISWatch citationsAbstractRelated PapersMolecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsPierre Sokoloff, Bruno Giros, Marie‐Pascale Martres et al.|Nature|1990|2.6kCloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1Roger K. Sunahara, Hong‐Chang Guan, Brian F. O’Dowd et al.|Nature|1991|1.2kReceptor activity and turnover of dopamine and noradrenaline after neurolepticsNils‐Erik Andén, Sherrel G. Butcher, H. Corrodi et al.|European Journal of Pharmacology|1970|1kHuman dopamine D1 receptor encoded by an intronless gene on chromosome 5Roger K. Sunahara, Hyman B. Niznik, David M. Weiner et al.|Nature|1990|465Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4.P Seeman|PubMed|1992|441